EPISODE · Jan 17, 2024 · 21 MIN
Targeting BTK and Bcl-2 for B-Cell Malignancies: Where Are We Moving Toward?
from Keeping Current CME
Expert insights on the latest clinical findings on targeting Bruton tyrosine kinase (BTK) and B-cell lymphoma 2 (Bcl-2) to treat B-cell malignancies. Credit available for this activity expires: 1/12/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999658?ecd=bdc_podcast_libsyn_mscpedu
Embed this episode
NOW PLAYING
Targeting BTK and Bcl-2 for B-Cell Malignancies: Where Are We Moving Toward?
0:00
21:28
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Keeping Current CME?
This episode is 21 minutes long.
When was this Keeping Current CME episode published?
This episode was published on January 17, 2024.
Can I download this Keeping Current CME episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!